Active Surveillance of Prostate Cancer

Article

Prostate cancer is the most common serious cancer in men and the second most common cause of death from cancer.

Prostate cancer is the most common serious cancer in men and the second most common cause of death from cancer. One in six men will be diagnosed with it during their lifetime resulting in about 200,000 new cases during the next 12 months. Despite the number of men affected, the prevention, diagnosis, and treatment of this disease probably are more controversial than any other cancer. Prostate Cancer: Reducing Your Risks explains both sides of the various controversies in an easy to understand manner. It provides you with balanced, unbiased information based on the best scientific studies available. Equipped with this information, you will be able to decide the best course of action to maximize your survival and your quality of life.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
Veeral Sheth, MD: Assessment of EYP-1901 Supplemental Injection Use in Wet AMD | Image Credit: University Retina
© 2024 MJH Life Sciences

All rights reserved.